What is the IMNM stock price prediction for next 2 weeks?

According to our price prediction algorithm,Immunome, Inc. (IMNM) price will be around $22.63 in the next 2 weeks. This means it will decrease by -1.6239130434782607 from the last closing price. This prediction may vary from other time period filters for IMNM stock.

What can be the highest Possible price of IMNM stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, IMNM can achieve the highest price of $23.49 which is 2.112406712541392 higher than last closing price. This prediction may vary from other time period filters for IMNM stock.

What can be the lowest Possible price of IMNM stock in next 2 weeks?

As per the forecast and algorithmic analysis, IMNM stock price can be as low as $21.78 which is -5.3260084595036075 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for IMNM stock.

Will IMNM stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that IMNM stock will lose-1.6239130434782607 in the next 2 weeks. This prediction may vary from other time period filters for IMNM stock.

What is IMNM stock last closing price?

Last closing price of IMNM stock was $23.00.

What is IMNM stock price prediction?

IMNM stock price prediction means predicting the future closing prices of IMNM stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of IMNM stock in a certain time period.

How we predict IMNM stock future prices?

If you are searching for IMNM stock forecast, analysis or price prediction, then you might be wondering what Immunome, Inc. (IMNM) will do in the future. Our IMNM price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This IMNM price prediction will likely answer most of your questions.

How frequent we update IMNM stock predictions?

We are updating the forecasts for the IMNM stock on daily basis.

Is using ML forecasting for IMNM stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for IMNM stock same for all the time periods?

No, the prediction for IMNM stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Immunome, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$23.00-2.99%Since 2 Weeks

Predicted Price$22.63-1.62%For 2 Weeks

Upper Predicted Price$23.492.11%For 2 Weeks

Lower Predicted Price$21.78-5.33%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of IMNM will decline by -1.62% over the next 2 Weeks and hit $22.63 by Monday, May 25, 2026. In that time frame, IMNM's share price is expected to range between $21.78 and $23.49.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 25, 2026	21.78	22.63	23.49
May 22, 2026	21.64	22.54	23.41
May 21, 2026	21.85	22.76	23.53
May 20, 2026	22.08	22.92	23.77
May 19, 2026	22.13	22.97	23.85
May 18, 2026	21.88	22.70	23.60
May 15, 2026	21.78	22.61	23.39
May 14, 2026	21.99	22.83	23.63
May 13, 2026	22.15	22.99	23.89
May 12, 2026	22.27	23.04	23.81

IMNM shares fell -2.59% in Tuesday, May 12, 2026's trading session, dropping from a previous close of $23.00 to move at $22.41. The stock demonstrated notable intraday movement (see IMNM's key stats for a full breakdown), fluctuating between $22.35 and $23.10, a +3.36% trading range. While recent weeks have seen some volatility, IMNM has managed to secure a -4.62% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 956.43K shares changing hands, 330.7K more than the previous session. This amounted to $21.43M in total market activity.

Will IMNM Continue Its Upward Trend?

According to analyst ratings and projections for IMNM, Immunome, Inc. shares are anticipated to increase by +4.60%, potentially reaching $23.49 per share by May 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for IMNM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the IMNM stock forecast, now is a good time to buy IMNM stock because its current trading price is -0.98% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on IMNM covering social and institutional perspectives.

IMNM Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into IMNM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.06% to 49.10%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 51.85%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.24%, maintains a neutral outlook for the long term. Insights into IMNM's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Immunome Short-Term Forecasts

IMNM Forecast For Next 5 Days

Our algorithm anticipates Immunome (IMNM) stock could hit $21.79 by May 19, 2026. This represents a -2.75% rise from today's price, following a +16.09% change over the past five days.

IMNM Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Immunome, Inc. (IMNM) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $22.64, which would mean a +1.05% increase from the current price of $22.41. Projections for this period range from a high of $25.07 to a low of $20.02.

IMNM Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Immunome's price over the next three months point to a rise. IMNM stock is expected to peak at $26.55 on Aug 12, 2026 after potentially dipping to $19.72 on Jun 09, 2026. On average, IMNM is likely to trade around $22.81 in the coming 90 days.

Immunome Stock Forecast 2025

Based on our predictive models, Immunome (IMNM) is expected to trade between $19.72 and $27.55 throughout 2026. This would result in an average price of $23.75, potentially offering investors a +6.00% return from current levels.

Immunome, Inc. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Immunome, Inc. (IMNM) is positioned to show a strong performance in May 2026. The price is predicted to move between $20.31 and $24.99, settling at an average of $22.62. This could translate to a +0.96% gain.

June 2026

Based on current market signals, Immunome, Inc. is projected to trend june 2026. We forecast a trading range from $19.72 to $25.06, with a likely average price of $22.22. Investors could expect a potential return of -0.83%.

July 2026

Our predictive algorithms indicate Immunome, Inc. stock may see a shift in July 2026. The expected range spans $20.29–$26.12, with an average target of $23.05. This represents a positive outlook and a possible gain of +2.88%.

August 2026

Analyzing established trends, Immunome, Inc. looks set to move in August 2026. Projections place the stock between $21.89 and $27.20, averaging around $24.61. This suggests a +9.84% gain from current levels.

September 2026

Market indicators suggest Immunome, Inc. could experience notable changes during September 2026. Prices could fluctuate within $22.54 to $27.47, with a midpoint forecast of $24.94. The stock might deliver a +11.31% gain.

October 2026

Forecasting for October 2026, models estimate that Immunome, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.46 and $27.18, averaging $23.97. This signals a positive trajectory with potential returns around +6.99%.

November 2026

According to our latest forecast models, Immunome, Inc. (IMNM) is positioned to show a strong performance in November 2026. The price is predicted to move between $21.12 and $26.71, settling at an average of $23.71. This could translate to a +5.82% gain.

December 2026

Based on current market signals, Immunome, Inc. is projected to trend december 2026. We forecast a trading range from $21.48 to $27.55, with a likely average price of $24.48. Investors could expect a potential return of +9.26%.

January 2027

Our predictive algorithms indicate Immunome, Inc. stock may see a shift in January 2027. The expected range spans $23.29–$28.59, with an average target of $26.04. This represents a positive outlook and a possible gain of +16.22%.

February 2027

Analyzing established trends, Immunome, Inc. looks set to move in February 2027. Projections place the stock between $23.93 and $28.85, averaging around $26.35. This suggests a +17.61% gain from current levels.

March 2027

Market indicators suggest Immunome, Inc. could experience notable changes during March 2027. Prices could fluctuate within $22.57 to $28.02, with a midpoint forecast of $25.37. The stock might deliver a +13.23% gain.

April 2027

Forecasting for April 2027, models estimate that Immunome, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $22.47 and $27.96, averaging $25.12. This signals a positive trajectory with potential returns around +12.12%.

May 2027

According to our latest forecast models, Immunome, Inc. (IMNM) is positioned to show a strong performance in May 2027. The price is predicted to move between $23.04 and $27.22, settling at an average of $25.10. This could translate to a +12.03% gain.

IMNM's history of dividends and stock splits also plays a role in long-term investor confidence.